{
    "clinical_study": {
        "@rank": "137807", 
        "acronym": "WINTAVI", 
        "brief_summary": {
            "textblock": "The study will evaluate all female patients with severe aortic stenosis undergoing\n      transcatheter valve implantation with commercially available valves and delivery systems."
        }, 
        "brief_title": "Women's INternational Transcatheter Aortic Valve Implantation Registry", 
        "completion_date": {
            "#text": "March 2019", 
            "@type": "Anticipated"
        }, 
        "condition": "Symptomatic Aortic Stenosis", 
        "condition_browse": {
            "mesh_term": [
                "Aortic Valve Stenosis", 
                "Constriction, Pathologic"
            ]
        }, 
        "detailed_description": {
            "textblock": "WINTAVI is an international, multi-centre, prospective, observational registry. The purpose\n      of this study is to collect 'real-world' data regarding the clinical utility of all\n      commercially available Transcatheter Aortic Valve Implantation (TAVI) devices for\n      percutaneous aortic valve implantation in female patients with severe Aortic Stenosis (AS)\n      requiring treatment. Data collected in this study will provide additional information on the\n      understanding of the safety and device performance in a 'real-world' setting and how to best\n      treat patients with severe AS. This will include Quality of Life  questionnaires (KCCQ)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Severe AS determined by echocardiogram and Doppler, defined as: mean gradient >40\n             mmHg or peak jet velocity >4.0 m/s and an aortic valve area \u22640.8 cm2 or aortic valve\n             area index \u22640.5 cm2/m2\n\n          2. Symptomatic AS demonstrated by angina, congestive heart failure, NYHA functional\n             class \u2265 II, or syncope\n\n          3. Logistic EuroSCORE  suitable for TAVI\n\n          4. Patient must have other conditions (such as severe airways disease, porcelain aorta,\n             previous thoracic radiotherapy, Childs Pugh class B and C liver disease) such that\n             the multi-disciplinary team (interventional cardiologists, cardiothoracic surgeons\n             and cardiac anaesthesiologists) agree that co-morbidities render SAVR of high or\n             prohibitive risk.\n\n          5. Patient has been informed of the nature of the registry and has provided full written\n             informed consent according to hospital practise\n\n        Exclusion Criteria:\n\n          1. Patient is not an eligible candidate for TAVI\n\n          2. Untreated clinically significant (> 70% obstruction) coronary artery disease in the\n             proximal segments of main branches suitable for revascularization\n\n          3. Echocardiographic evidence of intra-cardiac mass, thrombus or vegetation\n\n          4. Hemodynamic instability (e.g. requiring inotropic support)\n\n          5. Active endocarditis or sepsis within  6-months prior to the study procedure\n\n          6. Use of investigational device without CE mark"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Consecutive female patients with severe symptomatic Aortic Stenosis who are deemed\n        eligible for TAVI by a multi-disciplinary team in participating sites according to local\n        policy."
            }
        }, 
        "enrollment": {
            "#text": "1000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 22, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01819181", 
            "org_study_id": "WIN TAVI"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "TAVI", 
            "women", 
            "aortic stenosis", 
            "VARC2"
        ], 
        "lastchanged_date": "December 3, 2013", 
        "link": {
            "description": "Women in Innovations (\"WIN\")  mission is to address sex-based disparities in cardiovascular diagnosis, treatment and outcomes through innovative educational and research activities.", 
            "url": "http://www.scai.org/win"
        }, 
        "location": [
            {
                "contact": {
                    "email": "d.tchetche@clinique-pasteur.com", 
                    "last_name": "Didier Tchetche, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Toulouse", 
                        "country": "France", 
                        "state": "Midi-pyrenees", 
                        "zip": "31300"
                    }, 
                    "name": "Clinique PASTEUR"
                }, 
                "investigator": {
                    "last_name": "Didier Tchetche, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "t.lefevre@icps.com.fr", 
                    "last_name": "Thierry Lefevre, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Massy", 
                        "country": "France", 
                        "state": "Paris", 
                        "zip": "91300"
                    }, 
                    "name": "Hopital Jaques Cartier"
                }, 
                "investigator": {
                    "last_name": "Thierry Lefevre, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Le Chesnay", 
                        "country": "France", 
                        "zip": "78150"
                    }, 
                    "name": "H\u00f4pital Priv\u00e9 Parly 2"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lille Cedex", 
                        "country": "France", 
                        "zip": "59037"
                    }, 
                    "name": "Centre Hospitalier R\u00e9gional Universitaire de Lille"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toulouse", 
                        "country": "France", 
                        "zip": "50032"
                    }, 
                    "name": "Rangueil Hospital"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "contact": {
                    "email": "mehilli@dhm.mhn.de", 
                    "last_name": "Julinda Mehilli, MD", 
                    "phone": "49891218"
                }, 
                "facility": {
                    "address": {
                        "city": "Munich", 
                        "country": "Germany", 
                        "zip": "80636"
                    }, 
                    "name": "Deutsches Herzzentrum Munich"
                }, 
                "investigator": {
                    "last_name": "Julinda Mehilli, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "tambucor@unict.it", 
                    "last_name": "Corrado Tamburino, MD PhD", 
                    "phone": "00390957436205"
                }, 
                "facility": {
                    "address": {
                        "city": "Catania", 
                        "country": "Italy", 
                        "zip": "95124"
                    }, 
                    "name": "Azienda Ospedaliera Universitaria PO Ferrarotto"
                }, 
                "investigator": {
                    "last_name": "Corrado Tamburino, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "patrizia.presbitero@humanitas.it", 
                    "last_name": "Patrizia Presbitero, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Milan", 
                        "country": "Italy", 
                        "zip": "20089"
                    }, 
                    "name": "Istituto clinico humanitas"
                }, 
                "investigator": {
                    "last_name": "Patrizia Presbitero, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "chieffo.alaide@hsr.it", 
                    "last_name": "Alaide Chieffo, MD", 
                    "phone": "+390226437331", 
                    "phone_ext": "7331"
                }, 
                "facility": {
                    "address": {
                        "city": "Milan", 
                        "country": "Italy", 
                        "zip": "20132"
                    }, 
                    "name": "IRCCSSRaffaele Hospital"
                }, 
                "investigator": {
                    "last_name": "Alaide Chieffo, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "chiara_fraccaro@hotmail.com", 
                    "last_name": "Chiara Fraccaro, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Padova", 
                        "country": "Italy", 
                        "zip": "35139"
                    }, 
                    "name": "Department of Cardiac Thoracic and Vascular Sciences University of Padova"
                }, 
                "investigator": {
                    "last_name": "Chiara Fraccaro, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "as.petronio@gmail.com", 
                    "last_name": "Anna Sonia Petronio, MD", 
                    "phone": "050995244"
                }, 
                "facility": {
                    "address": {
                        "city": "Pisa", 
                        "country": "Italy", 
                        "zip": "56126"
                    }, 
                    "name": "Azienda ospedaliera universitaria Pisana Sezione Dipartimentale Laboratorio di Emodinamica P.O. Cisanello"
                }, 
                "investigator": {
                    "last_name": "Anna Sonia Petronio, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "rino.sardella@uniroma1.it", 
                    "last_name": "Gennaro Sardella, MD", 
                    "phone": "00390649979035"
                }, 
                "facility": {
                    "address": {
                        "city": "Rome", 
                        "country": "Italy"
                    }, 
                    "name": "Department cardiovascular Sciences Policlinico Umberto I"
                }, 
                "investigator": {
                    "last_name": "Gennaro Sardella, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Siena", 
                        "country": "Italy", 
                        "zip": "53100"
                    }, 
                    "name": "Univerisity of Siena, Department of Cardiovascular Diseases,Hospital Santa Maria alle Scotte"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "contact": {
                    "email": "emeliga@gmail.com", 
                    "last_name": "Emanuele Meliga, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Turin", 
                        "country": "Italy"
                    }, 
                    "name": "Mauriziano Hospital"
                }, 
                "investigator": {
                    "last_name": "Emanuele Meliga, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Riga", 
                        "country": "Latvia", 
                        "zip": "LV 1002"
                    }, 
                    "name": "Latvian Centre of Cardiology, Pauls Stradins Clinical University Hospital"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Riga", 
                        "country": "Latvia", 
                        "zip": "LV 1002"
                    }, 
                    "name": "Pauls Stradins Clinical University Hospital"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "contact": {
                    "email": "p.kievit@cardio.umcn.nl", 
                    "last_name": "Peter Kievit, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Radboud/Nijmegen", 
                        "country": "Netherlands", 
                        "zip": "9101"
                    }, 
                    "name": "Radboud University Nijmegen Medical Center"
                }, 
                "investigator": {
                    "last_name": "Peter Kievit, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "n.vanmieghem@erasmusmc.nl", 
                    "last_name": "Nicolas Van Mieghem, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Rotterdam", 
                        "country": "Netherlands", 
                        "zip": "3015 CE"
                    }, 
                    "name": "Erasmus Medical Center Rotterdam"
                }, 
                "investigator": {
                    "last_name": "Nicolas Van Mieghem, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "mcferrer10@gmail.com", 
                    "last_name": "Maria-Cruz Ferrer-Gracia"
                }, 
                "facility": {
                    "address": {
                        "city": "Zaragoza.", 
                        "country": "Spain", 
                        "zip": "50009"
                    }, 
                    "name": "Hospital Universitario Miguel Servet"
                }, 
                "investigator": {
                    "last_name": "Isabel Calvo Cebollero, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "France", 
                "Germany", 
                "Italy", 
                "Latvia", 
                "Netherlands", 
                "Spain"
            ]
        }, 
        "number_of_groups": "1", 
        "official_title": "Women's INternational Transcatheter Aortic Valve Implantation Registry", 
        "other_outcome": {
            "description": "Additional prosthetic valve performance endpoints include the following: prosthetic valve stenosis, prosthesis-patient mismatch, prosthetic valve regurgitation (central and paravalvular), effective orifice area and mean gradient, prosthetic valve malpositioning, TAV-in TAV deployment, prosthetic valve thrombosis, prosthetic valve endocarditis.\nAdditional TAVI related endpoints include the following: conduction disturbances and cardiac arrhythmias, coronary obstruction, conversion to open surgery, unplanned use of cardiopulmonary bypass, coronary obstruction, ventricular septal perforation, mitral valve apparatus damage or dysfunction and cardiac tamponade.\nAdditional clinical benefit endpoints include the following: NYHA functional assessment, Kansas City Cardiomyopathy Questionnaire(KCCQ) and six-minute walk test.", 
            "measure": "VARC 2, NYHA, KCCQ, six-minute walk test.", 
            "safety_issue": "Yes", 
            "time_frame": "30 days, 6 month, 1 year up to 5"
        }, 
        "overall_official": {
            "affiliation": "IRCCSSRaffaele and WINSCAI", 
            "last_name": "Alaide Chieffo, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Italy: Ethics Committee", 
                "Spain: Ethics Committee", 
                "Germany: Ethics Commission", 
                "France: Conseil National de l'Ordre des M\u00e9decins", 
                "France: The Commission nationale de l\u2019informatique et des libert\u00e9s"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary study endpoint is the VARC 2 early safety endpoint at 30-days (all-cause mortality, all stroke [disabling and non disabling], life-threatening bleeding, stage 2 or 3 acute kidney injury [AKI], coronary artery obstruction requiring intervention, major vascular complications, repeat procedure for valve-related dysfunction).", 
            "measure": "VARC 2", 
            "safety_issue": "Yes", 
            "time_frame": "30 days"
        }, 
        "reference": [
            {
                "PMID": "21930459", 
                "citation": "Buchanan GL, Chieffo A, Montorfano M, Maisano F, Latib A, Godino C, Cioni M, Gullace MA, Franco A, Gerli C, Alfieri O, Colombo A. The role of sex on VARC outcomes following transcatheter aortic valve implantation with both Edwards SAPIEN\u2122 and Medtronic CoreValve ReValving System\u00ae devices: the Milan registry. EuroIntervention. 2011 Sep;7(5):556-63. doi: 10.4244/EIJV7I5A91."
            }, 
            {
                "PMID": "23084102", 
                "citation": "Kappetein AP, Head SJ, G\u00e9n\u00e9reux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es GA, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rod\u00e9s-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB; Valve Academic Research Consortium-2. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg. 2013 Jan;145(1):6-23. doi: 10.1016/j.jtcvs.2012.09.002. Epub 2012 Oct 16. Review."
            }, 
            {
                "PMID": "21670242", 
                "citation": "Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, Serebruany V, Valgimigli M, Vranckx P, Taggart D, Sabik JF, Cutlip DE, Krucoff MW, Ohman EM, Steg PG, White H. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011 Jun 14;123(23):2736-47. doi: 10.1161/CIRCULATIONAHA.110.009449."
            }, 
            {
                "PMID": "22300690", 
                "citation": "Hayashida K, Morice MC, Chevalier B, Hovasse T, Romano M, Garot P, Farge A, Donzeau-Gouge P, Bouvier E, Cormier B, Lef\u00e8vre T. Sex-related differences in clinical presentation and outcome of transcatheter aortic valve implantation for severe aortic stenosis. J Am Coll Cardiol. 2012 Feb 7;59(6):566-71. doi: 10.1016/j.jacc.2011.10.877."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01819181"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "The clinical efficacy endpoint after 30-days (all-cause mortality, all stroke [disabling and non-disabling], requiring hospitalizations for valve related symptoms or worsening congestive heart failure, NYHA class III or IV, prosthetic valve dysfunction).\nAdditional individual safety endpoints include the following: all-cause mortality (procedural and 30-days), cardiovascular mortality, MI (peri-procedural and spontaneous), stroke (disabling and non-disabling), bleeding (life-threatening or disabling and major) and BARC type 3a-c and type 5a-b, AKI (stages 2 and 3), incidence of contrast-induced nephropathy, vascular complications (major and minor) and percutaneous closure device failure.", 
            "measure": "VARC 2 and BARC", 
            "safety_issue": "Yes", 
            "time_frame": "30 days, 6 month, 1 year up to 5"
        }, 
        "source": "Society for Cardiovascular Angiography and Interventions", 
        "sponsors": {
            "collaborator": {
                "agency": "Mount Sinai School of Medicine", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Society for Cardiovascular Angiography and Interventions", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "5 Years", 
        "verification_date": "December 2013"
    }
}